Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Patients hold overwhelming demand for GLP-1s, but access (supply + list price cost) creates constraints Employers and payors are grappling with benefit design and coverage access qualifications for GLP-1s (e.g., limiting to diabetes patients)
2023 Oct;93(5):401-409
Coding Tip: To reduce claim rejections, ensure documentation supports this as a non-specific or first-time presentation of constipation
In 2020, West Virginia launched a pilot program to subsidize the drugs for public employees
US$ 28.03
US$ 21.05
US$ 29.48
